PurMinds Announces Clinical Validation Collaboration with SpectroChip and Taiwan's Kaohsiung Municipal Siaogang Hospital
Five-year collaboration framework aims to advance point-of-care diagnostics, clinical performance evaluation, and precision-medicine applications LAS VEGAS and TORONTO, Oct. 14, 2026 /PRNewswire/ -- PurMinds Enterprises, Inc. (formerly Pacific Software, Inc.) (OTC: PFSF) ("PurMinds" or...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.